Amgen Inc (AMGN)

The California-based Amgen is a biotechnology firm that makes drugs aimed at battling anemia, blood disorders, and cancer by attacking the source of the disease - the genes.

Show Chart

Events

  • April202012
    Amgen Inc. expected to report Q1 2012 results on April 20, 2012. This event was calculated by Capital IQ (Created on January 28, 2012).
  • January262013
    Amgen Inc. expected to report Fiscal Year 2012 results on January 26, 2013. This event was calculated by Capital IQ (Created on January 28, 2012).

Members who own this company also own

the fun, safe & free way to learn the stock market Free! Sign up now! or log in

Current price per share

Today's gain: $-0.34 (-0.49%)

Is this a fair price given publicly available information?
(Not an indicator of whether the price will go up or down.)
Close Icon

Sign up or Sign in or continue to Explore We Seed